Get started
Author

Abhijit Debnath

Observed names: A. Debnath, ABHIJIT DEBNATH, Abhijeet Debnath
ORCID: 0000-0003-1056-1197
Observed ORCID: 0000-0003-1056-1197
OpenAlex ID: A5101728912
Advancements of Glucose Monitoring Biosensor: Current State, Generations of Technological Progress and Innovation Dynamics
2024 · Arpita Dua, Abhijit Debnath, et al. · Current Pharmaceutical Biotechnology · 27
In silico Identification of HDAC Inhibitors for Multiple Myeloma: A Structure-based Virtual Screening, Drug Likeness, ADMET Profiling, Molecular Docking, and Molecular Dynamics Simulation Study
2023 · Abhijit Debnath, Rupa Mazumder, et al. · Letters in Drug Design & Discovery · 19
Targeting Undruggable Proteins: The siRNA Revolution Beyond Small Molecules - Advances, Challenges, and Future Prospects in Therapeutic Innovation
2025 · Sk Ashif Jan, Abhijit Debnath, et al. · Current Gene Therapy · 17
Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive Review
2024 · Abhijit Debnath, Rupa Mazumder · Current Cancer Drug Targets · 15
Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products
2025 · Abhijit Debnath, Rupa Mazumder, et al. · PLoS ONE · 13
Discovery of novel CDK4/6 inhibitors from fungal secondary metabolites
2024 · Abhijit Debnath, Rupa Mazumder, et al. · International Journal of Biological Macromolecules · 12
Discovery of Novel PTP1B Inhibitors by High-throughput Virtual Screening
2024 · Abhijit Debnath, Anjna Rani, et al. · Current Computer - Aided Drug Design · 11
A Brief Study on Drug Repurposing: New Way of Boosting Drug Discovery
2022 · Rupa Mazumder, Kamal Kant Kaushik, et al. · Letters in Drug Design & Discovery · 11
Identification of Novel CDK 4/6 Inhibitors by High-throughput Virtual Screening
2024 · Abhijit Debnath, Rupa Mazumder · Letters in Drug Design & Discovery · 10
Unlocking the antimalarial potential of novel steroid-tetraoxane hybrids through consensus molecular docking and molecular dynamics investigation
2025 · Dipankar Nath, Abhijit Debnath, et al. · Scientific Reports · 8
PDF
Challenges and Progress of Orphan Drug Development for Rare Diseases
2025 · Abhijit Debnath, Rupa Mazumder, et al. · Current Pharmaceutical Biotechnology · 7
Experimental, quantum chemical spectroscopic investigation, topological, molecular docking/dynamics and biological assessment studies of 2,6-Dihydroxy-4-methyl quinoline
2024 · Rakesh Chandra Joshi, Shahid Husain, et al. · Journal of Molecular Structure · 7
Role of PD ‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance
2024 · Neha Sharma, Rupa Mazumder, et al. · Chemical Biology & Drug Design · 7
Discovery of novel HBV core protein inhibitors by high throughput virtual screening
2025 · Jahanvi Sanchitra, Abhijit Debnath, et al. · Scientific Reports · 5
PDF
Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
2024 · Saloni Mangal, Abhijit Debnath, et al. · All Life · 5
PDF
A Deep Dive into PDE5 Inhibition: Innovative Discoveries via Virtual Screening
2024 · Abhijit Debnath, Hema Chaudhary, et al. · Letters in Drug Design & Discovery · 4
Development and Evaluation of a Baicalin-loaded Phytosomal Transdermal Patch for Type 2 Diabetes Mellitus
2026 · Priya Singhal, Rupa Mazumder, et al. · Current Drug Metabolism · 3
Transferosomes: A Vesicular Tool for Transdermal Drug Delivery
2026 · Arpita Dua, Rupa Mazumder, et al. · Current Pharmaceutical Design · 3
Antihypertensive potential of diosgenin: A comparative pharmacoinformatics study
2025 · Shiwani Chahal, Abhijit Debnath, et al. · Computers in Biology and Medicine · 3
Design, synthesis, docking, DFT, and MD simulation studies of new piperazine, 1,3,4-oxadiazole, and quinoline conjugates: A search for potent antiepileptic agents
2025 · Shrishti Tripathi, Rajnish Kumar, et al. · Bioorganic Chemistry · 3
Quest for discovering novel CDK12 inhibitor
2024 · Abhijit Debnath, Rajesh Kumar Singh, et al. · Journal of Receptors and Signal Transduction · 3
PDF
miRNA-Targeted Vaccines: A Promising Approach for Viral Attenuation and Immunogenicity Enhancement
2024 · Abhijit Debnath, Rupa Mazumder, et al. · Current Gene Therapy · 3
Three-Dimensional Hydrogel Bioprinting Technology as a Scaffold of Novel Drug Delivery and Biomedical Devices: A Comprehensive Review
2024 · Mohhammad Ramzan, Mohammed Sabir, et al. · BIO Web of Conferences · 3
PDF
In Search of Novel SGLT2 Inhibitors by High-throughput Virtual Screening
2023 · Abhijit Debnath, Shalini Sharma, et al. · Current Drug Discovery Technologies · 3
A Brief Description of Covid-19 Pulmonary Viral Infection and Repurposing of Drugs for Its Treatment
2022 · MANISHA PATEL, RUPA MAZUMDER, et al. · International Journal of Applied Pharmaceutics · 3
PDF
Works count: 61
Citation count: 225
H-index: 9
I10-index: 9
Year
Topic
Type